In HR‐deficient tumor cells, where DSB repair relies on compensatory NHEJ, genomic instability is exacerbated, driving the synthetic lethality associated with BRCA1 deficiency and PARP inhibition [65]. This evidence concerns the gene BRCA1 and neoplasm.